Etodolac

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2M36281008, chemically known as 1,3,4,9-tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid but generally known as etodolac, which bears US NIH Compound Identifier 3308. European Medicines Agency schedules Etodolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07316MIG. The term ETODOLAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules etodolac in its Anatomical Therapeutic Chemical (ATC) Classification. ETODOLAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etodolac under HS 29349990 and SITC 51579. As of Q4 2014, ETODOLAC remains the US FDA Preferred Term for this commodity. Etodolac bears US NLM identifiers UMLS ID C0059865 and NCI Concept Code C47526. SMILES: O1C(C2[NH]C3C(C2CC1)CCCC3CC)(CC)CC(=O)O.